Ticker Details
BioLife Solutions, Inc. BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
IPO Date:	October 1, 2002
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$989.18M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 2.95%
Avg Daily Range (30 D):	$0.47 | 2.36%
Avg Daily Range (90 D):	$0.44 | 1.96%

Institutional Daily Volume
Avg Daily Volume:	.23M
Avg Daily Volume (30 D):	.38M
Avg Daily Volume (90 D):	.29M

Trade Size
Avg Trade Size (Sh.):	74
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	47

Institutional Trades
Total Institutional Trades:	1,578
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.43M
Avg Institutional Trade (90 D):	$1.37M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$1.66M
Avg Closing Trade (90 D):	$1.54M
Avg Closing Volume:	59.94K

News

Feb 26, 2026 @ 9:03 PM BioLife Solutions Reports Fourth Quarter and Full ... Source: Prnewswire

Feb 17, 2026 @ 1:04 PM BioLife Solutions to Report Fourth Quarter and Ful... Source: Prnewswire

Feb 12, 2026 @ 1:03 PM BioLife Solutions Signs Multi-Year Supply Agreemen... Source: Prnewswire

Feb 11, 2026 @ 6:40 PM Bio-Preservation Market to Reach US$ 44.45 Billion... Source: Astute Analytica

Jan 12, 2026 @ 1:03 PM BioLife Solutions Announces Preliminary Fourth Qua... Source: Prnewswire

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.09	$.24	$-.09
Diluted EPS	$-.1	$.23	$-.1
Revenue	$96.21M	$18.79M	$96.21M
Gross Profit	$62.12M		$62.12M
Net Income / Loss	$-4.6M	$11.07M	$-4.6M
Operating Income / Loss	$-16.6M	$1.35M	$-16.6M
Cost of Revenue	$34.1M		$34.1M
Net Cash Flow	$-62.35M	$3.56M	$-62.35M
PE Ratio

Splits
Jan 29, 2014	1:14